Engineered Exosome Platform
Echosome® is Echo biotech's engineered exosome platform, enabling efficient exosomal loading for five molecular categories: intra-membranous proteins, extra-membranous proteins, small RNA, mRNA, and small molecules. Depending on target objectives and molecule types, the platform provides two technical routes: endogenous loading and exogenous loading. In April 2024, foundational research from Echo biotech's engineered exosome technology platform was published in the top exosome journal, Journal of Extracellular Vesicles. The study identified a novel scaffold protein, PLXNA1, which enables highly efficient protein cargo loading both inside and outside exosomes and significantly outperforms existing scaffold proteins. This publication represents that Echo biotech's Echosome® engineered exosome platform is operating at an international leading level.
Quick Facts
- Carrier Design: Engineering design for protein / nucleic acid delivery goals.
- Loading & Modification: Supports loading, surface engineering, and functional evaluation.
- Efficient Targeting: Supports exosome-surface targeting ligands such as peptides, minibinders, nanobodies, and scFv for targeted delivery to specific cells or tissues.
FAQ
- What does the Engineered Exosome Platform page cover?
- Engineered Exosome Platform is an Echo Biotech technology platform page. Echosome® is Echo biotech's engineered exosome platform, enabling efficient exosomal loading for five molecular categories: intra-membranous proteins, extra-membranous proteins, small RNA, mRNA, and small molecules.
- What directions are included under Engineered Exosome Platform?
- This page includes directions such as Carrier Design, Loading & Modification, and Efficient Targeting.
- How can customers learn more about Engineered Exosome Platform?
- Customers can open the related detail pages for specific information or contact Echo Biotech to confirm specifications, sample requirements, service workflows, or collaboration options.